BSEInsider Trading / SAST3d ago · 17 Aug 2026, 02:03 pm

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Malabar India Fund Ltd

Neuland Laboratories Ltd · 524558

✦ AI SummaryPledge

Malabar India Fund Ltd has disclosed selling 2,72,634 equity shares of Neuland Laboratories Ltd in the secondary market, resulting in a 2.12% stake reduction.

Analysis Scores

Earnings Impact2/10
Growth Catalyst2/10
Governance Concern2/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Neuland Laboratories Ltd - 524558 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Attachments (1)

📄

E9CB3BE8_599E_41CB_813C_1B48DFD5ECD3_140311.pdf

pdf

Download →
View document text
MALABAR INDIA FUND LIMITED 6th Floor, Two Tribeca, Tribeca Central, Trianon 72261, Republic of Mauritius Tel: + (230) 404 8800 Fax: + (230) 404 8899 Email: malabarfund@apex.mu Aug 14, 2026 Department of Corporate Affairs BSE Limited National Stock Exchange of India Limited P.J Tower, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai-400001 Bandra Kurla Complex, Bandra (E) Mumbai 400 051 Sub: Intimation/Disclosure under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Dear Sir, With reference to the captioned subject, please find enclosed (as Annexure - 1) the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 pursuant to sell of 2,72,634 equity shares of Neuland Laboratories Ltd in secondary market. We request you to take the same on your records. Thanking You, For Malabar India Fund Limited Mohinee Bhollah Director Encl: as above Licensed by the Financial Services Commission of Mauritius ANNEXURE 1 FormatfordisclosuresunderRegulation29(2)ofSEBI(SubstantialAcquisitionofSharesand Takeovers)Regulations,2011 Part-A-Detailsofthesale NEULANDLABORATORIESLIMITED NameoftheTargetCompany(TC) MalabarIndiaFundLimited Name(s)ofthesellerandPersonsActinginConcert(PAC) withtheseller WhetherthesellerbelongstoPromoter/Promotergroup BSELimited&NationalStockExchangeof Name(s)oftheStockExchange(s)wherethesharesofTC IndiaLimited areListed Number %w.r.t.total %w.r.t.total share/voting diluted Detailsoftheacquisitionasfollows capital share/voting wherever capitalofthe applicable(*) TC(**) Beforethesale/dilutionunderconsideration,holdingof selleralongwithPACsof: a) Sharescarryingvotingrights 9,21,371 7.18% 7.18% b) Sharesinthenatureofencumbrance(pledge/lien/ Nil N.A N.A non-disposalundertaking/others) c) Votingrights(VR)otherwisethanbyequityshares Nil N.A N.A d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying Nil N.A N.A voting rights in the TC (specify holding in each category) e) Total(a+b+c+d) 9,21,371 7.18% 7.18% Detailsofsale a) Sharescarryingvotingrightssold 2,72,634 2.12% 2.12% b) VRssoldotherwisethanbyequityshares Nil N.A N.A c) Warrants/convertible securities/any other instrument Nil N.A N.A that entitles the seller to sell shares carrying voting rightsintheTC(specifyholdingineachcategory)sold d) Sharesinthenatureofencumbrance(pledge/lien/ non-disposalundertaking/others) Nil N.A N.A e) Total(a+b+c+d) 2,72,634 2.12% 2.12% AftertheSale/dilution,holdingofselleralongwith PACsof: a) Sharescarryingvotingrights 6,48,737 5.06% 5.06% b) VRsotherwisethanbyequityshares Nil N.A N.A c) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying Nil N.A N.A voting rights in the TC (specify holding in each category)afteracquisition d) Sharesinthenatureofencumbrance(pledge/lien/ Nil N.A N.A non-disposalundertaking/others) e) Total(a+b+c+d) 6,48,737 5.06% 5.06% Openmarket Mode of sale (e.g. open market / public issue / rights issue / preferential allotment / inter-se transfer/encumbrance, etc.) anddilution N.A. Salientfeaturesofthesecuritiesacquiredincludingtimetill redemption,ratioatwhichitcanbeconvertedintoequity shares,etc. Between10August2024till14Aug2026 Dateofsale/dateofreceiptofintimationofallotmentofshares /VR/warrants/convertiblesecurities/anyotherinstrumentthat entitlestheacquirertoreceivesharesintheTC. Rs12,82,98,890/-consistingof1,28,29,889 Equitysharecapital/totalvotingcapitaloftheTCbeforethe equitysharesofRs10/-each. saidsale Rs12,82,98,890/-consistingof1,28,29,889 Equitysharecapital/totalvotingcapitaloftheTCafterthe equitysharesofRs10/-each. saidsale Rs12,82,98,890/-consistingof1,28,29,889 Totaldilutedshare/votingcapitaloftheTCafterthesaidsale. equitysharesofRs10/-each. Part-B*** Name of the Target Company: NEULAND LABORATORIES LIMITED Name(s) of the seller and Whether the seller PAN of the seller Persons Acting in Concert belongs to Promoter/ and/ or PACs (PAC) with the seller Promoter group Malabar India Fund Limited No AAFCM6589C For. Malabar India Fund Limited Mohinee Bhollah Director / Authorised Signatory Date: Aug 14, 2026 Place: Mauritius Note: (*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement. (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. (***) Part-B shall be disclosed to the Stock Exchanges but shall not be disseminated. ******